Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application.
about
Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stabilitySkin vaccination against cervical cancer associated human papillomavirus with a novel micro-projection array in a mouse model.A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity.A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution.Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation.Influence of protein conformation and adjuvant aggregation on the effectiveness of aluminum hydroxide adjuvant in a model alkaline phosphatase vaccine.Stabilization of a recombinant ricin toxin A subunit vaccine through lyophilization.Phytol-derived novel isoprenoid immunostimulants.Spray drying and vaccine stabilization.Intradermal powder immunization with protein-containing vaccines.From Stock Bottle to Vaccine: Elucidating the Particle Size Distributions of Aluminum Adjuvants Using Dynamic Light ScatteringDevelopment of thermostable lyophilized inactivated polio vaccine.Toward intradermal vaccination: preparation of powder formulations by collapse freeze-drying.Developments in the formulation and delivery of spray dried vaccines.The immunogenicity of thin-film freeze-dried, aluminum salt-adjuvanted vaccine when exposed to different temperatures.Methods to Prepare Aluminum Salt-Adjuvanted Vaccines.Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action
P2860
Q24634332-815C2420-F9CE-4DDF-81EB-BB98A92FC366Q33728320-E499A657-137A-407D-923E-5FEE96AB88C8Q33731533-04EE77A1-09A4-473A-9DB6-AE844B6CA688Q35268788-BED901A0-1BC1-4B60-9FA4-5EA059231B2BQ36968256-CF3A1A65-025B-44C1-9794-CBA7F92514FDQ36994089-D028DE04-9A29-4C76-AEC9-F02CCCC75E8AQ37231025-C2270DE9-B119-4F75-8344-0078232FCBF7Q38008360-5149FB86-3DD1-4CE7-A002-9F3544EF9B6DQ38062028-CD5C1800-4505-4934-AFA8-76A8B11382BAQ38113271-D13644AA-B7C1-43B8-AD0C-CFC1F9694F1EQ40959511-22E62690-4A1E-478E-BBA7-0BAC546AD3AEQ42222649-3F0FE2F1-3FCD-4DCC-91E1-CD7455F05662Q45288735-35E8B778-49C3-4114-AF85-25F3752974A9Q47106090-C15FEE43-70DF-4D06-8AA4-343FC00D9FBEQ47121608-210456D0-7D08-40E4-B587-E95A0D235AE1Q54311492-70BCDC3B-4DF7-4EBE-BCF9-0BE58DF51EEEQ59137099-5E8CE4D0-A9D2-412C-BEC1-67130C1A2E48
P2860
Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Stabilization of alum-adjuvant ...... ns: mechanism and application.
@en
type
label
Stabilization of alum-adjuvant ...... ns: mechanism and application.
@en
prefLabel
Stabilization of alum-adjuvant ...... ns: mechanism and application.
@en
P2093
P356
P1476
Stabilization of alum-adjuvant ...... ns: mechanism and application.
@en
P2093
Dexiang Chen
Lendon G Payne
Yuh-Fun Maa
P304
P356
10.1002/JPS.10294
P407
P577
2003-02-01T00:00:00Z